NASDAQ:GRCE | Income Statement | Grace Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$697,000.00-$15.92M$127,000.00-$15.79M$0.00-$15.79M-$0.91-$0.9117,269,98617,269,986
2026-03-31$420,000.00-$3.01M$132,000.00-$2.88M-$1.7M-$1.18M-$0.06-$0.06248,521248,521
2025-12-31$462,000.00-$2.45M$134,000.00-$2.32M$0.00-$2.32M-$0.14-$0.1416,933,62016,933,620
2025-09-30$568,000.00-$2.53M$1.59M-$938,000.00$0.00-$938,000.00-$0.06-$0.0615,924,52215,924,522
2025-06-30$955,000.00-$3.09M-$272,000.00-$3.36M$0.00-$3.36M-$0.21-$0.2115,924,52215,924,522
2025-03-31$1.63M-$3.18M$2.8M-$382,000.00-$1.02M$636,000.00$0.10$0.10581,036581,036
2024-12-31$2.19M-$3.7M-$1.06M-$4.76M-$605,000.00-$4.16M-$0.36-$0.3611,506,23411,506,234
2024-09-30$2.98M-$4.83M$547,000.00-$4.28M-$852,000.00-$3.43M-$0.30-$0.3011,506,23411,506,234
2024-06-30$2.71M-$4.96M$1.62M-$3.34M-$724,000.00-$2.62M-$0.24-$0.2410,928,54310,928,543
2024-03-31$1.69M-$3.26M-$792,000.00-$4.06M-$889,000.00-$3.17M-$0.26-$0.26654,251654,251
2023-12-31$1.44M-$3.04M$444,000.00-$2.6M-$208,000.00-$2.39M-$0.21-$0.2111,506,25711,506,257
2023-09-30$460,000.00-$2.09M-$1.63M-$3.72M-$446,000.00-$3.27M-$0.43-$0.437,552,6777,552,677
2023-06-30$1.1M-$4.45M$142,000.00-$4.31M-$289,000.00-$4.02M-$0.54-$0.547,435,5337,435,533
2023-03-31$1.64M-$38.07M$115,000.00-$37.96M-$8.87M-$29.09M-$3.91-$3.9119,15419,154
2022-12-31$2.45M-$4.25M$82,000.00-$4.16M-$274,000.00-$3.89M-$0.52-$0.527,435,4727,435,472
2022-09-30$3.29M-$5.11M$24,000.00-$5.08M-$155,000.00-$4.93M-$0.66-$0.667,425,1667,425,166
2022-06-30$2.59M-$4.73M-$36,000.00-$4.77M-$242,000.00-$4.52M-$0.61-$0.617,388,0657,388,065
2022-03-31$0.00$0.00$2.33M-$4.4M-$149,000.00-$4.55M-$648,000.00-$3.9M-$0.04-$0.0411,056,18311,056,183
2021-12-31$0.00$0.00$2.18M-$4.47M$696,000.00-$3.78M$0.00-$3.78M-$0.09-$0.0944,288,18344,288,183
2021-09-30$585,000.00-$3.57M$4.55M$981,000.00$0.00$981,000.00-$0.03-$0.0332,788,27532,788,275
2021-06-30$469,000.00-$3.15M$27,000.00-$3.12M$0.00-$3.12M-$0.12-$0.1226,046,95026,046,950
2021-03-31$115,000.00$40,000.00$453,000.00-$2.3M-$3.35M-$5.65M2,906,113
2020-12-31$81,000.00$36,000.00$678,000.00-$1.96M-$1.26M-$3.22M12,533,584
2020-09-30$1.29M-$8.03M$1.89M-$6.15M11,889,941
2020-06-30$1.76M-$4.12M-$545,000.00-$4.67M90,691,726
2020-03-31$1.92M-$4.03M$20.65M$16.62M1,764,481
2019-12-31$3.91M-$6.15M-$5.98M-$12.12M86,767,312
2019-09-30$3.95M-$6.26M-$14.9M-$21.16M83,092,037
2019-06-30$6.19M-$8.01M-$840,000.00-$8.85M78,638,075

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-03-31$2.41M-$11.08M$1.58M-$9.49M-$1.7M-$7.79M-$0.47-$0.4716,510,63216,510,632
2025-03-31$9.51M-$16.68M$3.91M-$12.77M-$3.2M-$9.57M-$0.79-$0.7912,087,27012,087,270
2024-03-31$4.68M-$12.85M-$1.83M-$14.69M-$1.83M-$12.85M-$1.35-$1.359,529,1239,529,123
2023-03-31$9.97M-$52.16M$184,000.00-$51.97M-$9.54M-$42.43M-$5.71-$5.717,435,4727,435,472
2022-03-31$0.00$0.00$5.56M-$15.59M$5.12M-$10.47M-$648,000.00-$9.82M-$0.27-$0.2736,841,76236,841,762
2021-03-31$196,000.00$76,000.00$4.17M-$16.42M-$3.26M-$19.68M$0.00-$19.68M14,828,232
2020-03-31$15.97M-$24.44M-$1.08M-$25.51M$0.00-$25.51M84,581,764
2019-03-31$29.37M-$34.41M-$4.96M-$39.37M$0.00-$39.37M54,290,295